The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life (QoL) in a phase III trial of pelvic external beam radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk, early stage endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group study.
 
Vivian Vongruenigen
No Relationships to Disclose
 
Helen Q Huang
No Relationships to Disclose
 
David Cella
Stock and Other Ownership Interests - FACIT.org
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; GlaxoSmithKline; Novartis; Pfizer; PledPharma; Puma Biotechnology
Research Funding - Bayer (Inst); Genentech (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen
 
Marcus Randall
No Relationships to Disclose
 
Robert S. Mannel
Consulting or Advisory Role - Clovis Oncology (Inst); Tesaro (Inst)
 
Byoung-Gie Kim
No Relationships to Disclose
 
Ritu Salani
Honoraria - AstraZeneca; Clovis Oncology; Tesaro
Consulting or Advisory Role - Genentech/Roche
 
James J Burke
No Relationships to Disclose
 
Thomas J. Rutherford
No Relationships to Disclose
 
Nick Spirtos
No Relationships to Disclose
 
Katina Robison
No Relationships to Disclose
 
Lari B. Wenzel
Consulting or Advisory Role - Array BioPharma; Array BioPharma